eptaloprost

prodrug for cicaprost; structure given in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Neoplasms (Cancer) 01/01/1991 - "These data show that the prostacyclin analogue Eptaloprost has a significant antimetastatic activity in a spontaneously metastasizing tumor model and thus merits further investigation."
2.	Neoplasm Metastasis (Metastasis) 01/01/1991 - "There was a considerable reduction of the number of visible lung metastases by Eptaloprost. "
3.	Carcinoma (Carcinomatosis) 01/01/1991 - "To investigate the antimetastatic potential of two prostacyclin analogues (Iloprost and Eptaloprost, Schering AG), we have tested these compounds in the spontaneously metastasizing R 3327 MAT Lu prostate carcinoma of the Cop rat in two types of experiments. "